Table 2.
Age and gender-specific self-reported conditions, undiagnosed conditions and biomarkers for the CCHC study1
| Total | 18-29 | 30-39 | 40-49 | 50-59 | 60-69 | 70+ | |
|---|---|---|---|---|---|---|---|
| Body Mass Index | |||||||
| All Obese (BMI ≥ 30) | |||||||
| Women | 717 (51.5)* | 80(41.3) | 169 (46.0) | 173 (58.8) | 163 (60.4) | 87 (60.2) | 45 (49.0) |
| Men | 300 (44.8) | 44 (38.3) | 88 (57.2) | 71 (43.4) | 49 (47.1) | 30 (36.1) | 18 (42.5) |
| Obese Category III(BMI ≥ 40) | |||||||
| Women | 132 (9.7)** | 16 (11.7) | 31 (7.7) | 32 (10.5) | 27 (9.3) | 14 (7.5) | 12 (13.0) |
| Men | 38 (5.7) | 7(6.2) | 13 (7.9) | 11 (5.6) | 4 (4.8) | 3 (6.7) | 0 (0.0) |
| Obese Category II (BMI 35-39) | |||||||
| Women | 185 (12.6)* | 19 (6.9) | 43 (11.2) | 53 (19.4) | 42 (15.3) | 19 (16.7) | 9 (6.6) |
| Men | 66 (10.6) | 8 (4.9) | 29 (21.4) | 12 (9.4) | 9 (10.6) | 4 (4.8) | 4 (9.0) |
| Obese Category I (BMI 30-34) | |||||||
| Women | 394 (28.9) | 45 (22.8) | 95 (27.1) | 86 (28.5) | 93(35.4) | 52 (34.9) | 23 (28.5) |
| Men | 194 (27.9) | 29 (27.1) | 46 (27.8) | 48 (28.5) | 35 (30.9) | 23 (24.7) | 13 (28.9) |
| Overweight (BMI 25 to 29) | |||||||
| Women | 393 (30.2)*** | 56 (29.0) | 95 (31.1) | 93 (29.6) | 81 (31.0) | 43 (27.9) | 25 (33.1) |
| Men | 241 (36.9) | 36 (30.3) | 42 (32.9) | 58 (37.9) | 50 (40.8) | 42 (54.7) | 13 (30.8) |
| Normal/ Underweight (BMI < 25) | |||||||
| Women | 230 (18.2) | 72 (29.7) | 63 (22.9) | 35 (11.6) | 23 (8.6) | 21 (11.7) | 16 (16.7) |
| Men | 109(17.9) | 28 (31.4) | 22 (9.0) | 23 (18.7) | 15 (11.8) | 9 (8.2) | 12 (25.3) |
| Diabetes | |||||||
| Diagnosed Diabetes (n (%)) | |||||||
| Women | 194 (13.3) | 6 (3.3) | 16 (3.9) | 36 (11.1) | 54 (19.4) | 51 (31.5) | 31 (28.6) |
| Men | 100 (14.1) | 3 (2.0) | 8 (7.0) | 20 (11.2) | 31 (26.2) | 30 (36.6) | 8 (16.7) |
| Undiagnosed Diabetes (n (%)) | |||||||
| Women | 44 (2.4)*** | 4 (1.4) | 5 (1.1) | 17 (4.9) | 14 (4.6) | 3 (1.4) | 1 (1.5) |
| Men | 40 (6.2) | 3 (3.1) | 4 (4.0) | 14 (8.7) | 13 (12.3) | 5 (7.7) | 1 (3.1) |
| Total Diabetes (n (%)) | |||||||
| Women | 239 (15.8)* | 10 (4.7) | 21 (5.0) | 54 (16.3) | 68 (24.0) | 54 (32.9) | 32 (30.1) |
| Men | 141 (20.4) | 6 (5.2) | 11 (9.9) | 35 (20.5) | 45 (40.3) | 35 (44.3) | 9 (19.8) |
| Blood Pressure | |||||||
| Self-Reported Hypertension (n (%)) | |||||||
| Women | 356 (26.2)* | 8 (4.2) | 27 (7.8) | 68 (22.4) | 102 (37.7) | 88 (59.2) | 63 (63.8) |
| Men | 149 (20.1) | 6 (4.1) | 14 (6.3) | 22 (12.1) | 45 (35.8) | 42 (53.7) | 20 (36.1) |
| Systolic BP > 140 no SR | |||||||
| Hypertension (n(%)) | |||||||
| Women | 61 (6.7) | 0 (.00) | 2 (.37) | 16 (6.3) | 24 (17.6) | 15 (26.3) | 4 (27.9) |
| Men | 25 (4.5) | 1(.73) | 3 (.77) | 2 (2.6) | 9 (12.2) | 6(15.2) | 4 (13.5) |
| Cholesterol | |||||||
| Self-Reported High Cholesterol (n (%)) | |||||||
| Women | 316 (22.5) | 12 (7.1) | 30 (10.4) | 65 (21.2) | 101 (34.8) | 67 (43.3) | 41 (40.5) |
| Men | 173 (24.7) | 7 (6.7) | 28 (19.4) | 40 (21.0) | 49 (44.1) | 35 (48.4) | 14 (26.9) |
| Serum cholesterol ≥ 200 (n(%))2 | |||||||
| Women | 460 (32.9)** | 30(14.7) | 76 (19.9) | 115 (38.0) | 136 (49.4) | 69 (49.9) | 34 (46.1) |
| Men | 264 (36.9) | 23(18.5) | 69 (43.2) | 75 (50.5) | 52 (47.0) | 32 (39.5) | 13 (22.8) |
| HDL ≥ 60 (n (%)) | |||||||
| Women | 212 (14.3)*** | 30(13.2) | 46 (11.9) | 37 (12.8) | 52 (19.2) | 31 (15.4) | 16 (15.7) |
| Men | 45 (4.3) | 4(6.2) | 8 (4.0) | 12 (6.5) | 11 (8.4) | 7 (12.4) | 3 (4.3) |
| LDL ≥ 130 (n (%)) | |||||||
| Women | 306 (22.6)** | 22 (12.2) | 59 (15.8) | 75 (25.7) | 86 (32.2) | 42 (32.1) | 22 (30.1) |
| Men | 176 (26.1) | 15(13.6) | 49 (35.0) | 51 (33.4) | 31 (32.6) | 21 (25.1) | 9 (16.7) |
1
* p<.05, ** p<.01, *** p<.001
2
Serum Cholesterol ≥ 200 for entire sample regardless of self-report status.